156 related articles for article (PubMed ID: 25979969)
1. A cell-based screening for TAZ activators identifies ethacridine, a widely used antiseptic and abortifacient, as a compound that promotes dephosphorylation of TAZ and inhibits adipogenesis in C3H10T1/2 cells.
Kawano S; Maruyama J; Nagashima S; Inami K; Qiu W; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
J Biochem; 2015 Nov; 158(5):413-23. PubMed ID: 25979969
[TBL] [Abstract][Full Text] [Related]
2. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
[TBL] [Abstract][Full Text] [Related]
3. Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes.
Komatsu N; Kajiya M; Motoike S; Takewaki M; Horikoshi S; Iwata T; Ouhara K; Takeda K; Matsuda S; Fujita T; Kurihara H
Stem Cell Res Ther; 2018 Dec; 9(1):342. PubMed ID: 30526677
[TBL] [Abstract][Full Text] [Related]
4. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ.
Jang EJ; Jeong H; Kang JO; Kim NJ; Kim MS; Choi SH; Yoo SE; Hong JH; Bae MA; Hwang ES
Br J Pharmacol; 2012 Mar; 165(5):1584-94. PubMed ID: 21913895
[TBL] [Abstract][Full Text] [Related]
5. Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model.
Yang Z; Nakagawa K; Sarkar A; Maruyama J; Iwasa H; Bao Y; Ishigami-Yuasa M; Ito S; Kagechika H; Hata S; Nishina H; Abe S; Kitagawa M; Hata Y
Mol Cell Biol; 2014 May; 34(9):1607-21. PubMed ID: 24550007
[TBL] [Abstract][Full Text] [Related]
6. Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ.
Guo L; Cai T; Chen K; Wang R; Wang J; Cui C; Yuan J; Zhang K; Liu Z; Deng Y; Xiao G; Wu C
J Cell Biol; 2018 Apr; 217(4):1431-1451. PubMed ID: 29496737
[TBL] [Abstract][Full Text] [Related]
7. TAZ Induction Directs Differentiation of Thyroid Follicular Cells from Human Embryonic Stem Cells.
Ma R; Morshed SA; Latif R; Davies TF
Thyroid; 2017 Feb; 27(2):292-299. PubMed ID: 27829313
[TBL] [Abstract][Full Text] [Related]
8. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
[TBL] [Abstract][Full Text] [Related]
9. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
Nagashima S; Bao Y; Hata Y
Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.
Ando T; Charindra D; Shrestha M; Umehara H; Ogawa I; Miyauchi M; Takata T
Oncogene; 2018 Jan; 37(2):263-270. PubMed ID: 28925394
[TBL] [Abstract][Full Text] [Related]
11. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
12. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.
Liu CY; Lv X; Li T; Xu Y; Zhou X; Zhao S; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2011 Feb; 286(7):5558-66. PubMed ID: 21189257
[TBL] [Abstract][Full Text] [Related]
13. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
14. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
15. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
16. TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner.
Remue E; Meerschaert K; Oka T; Boucherie C; Vandekerckhove J; Sudol M; Gettemans J
FEBS Lett; 2010 Oct; 584(19):4175-80. PubMed ID: 20850437
[TBL] [Abstract][Full Text] [Related]
17. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization.
Yoo G; Kim T; Chung C; Hwang DS; Lim DS
Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071
[TBL] [Abstract][Full Text] [Related]
18. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
Kim M; Kim T; Johnson RL; Lim DS
Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
[TBL] [Abstract][Full Text] [Related]
20. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]